Viridian Therapeutics (VRDN) Stock Insights
VRDN$24.27+0.18 +0.75%
$2.75B
Market Cap
-6.61
P/E
17.28
Forward P/E
—
Score
Viridian Therapeutics (VRDN) Stock Insights
VRDN price $24.27 +0.18 +0.75%
- Ticker
- VRDN
- Price
- $24.27
- Change
- +0.18 +0.75%
- Market cap ?
- $2.75B
- P/E ?
- -6.61
- Forward P/E ?
- 17.28
- Dividend yield ?
- 0.00%
- Beta ?
- 0.96
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3337000 | 4003000 | 8386000 | 4461000 | 1050000 | 2963000 | 1772000 | 314000 | 302000 | 70849000 |
Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation…
Fair value
VRDN fair value $30.83. Price $24.27. Price is 21% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 14.87M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.60% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 113.29M. Net debt -161.69M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -1.02 | — | 4.72M |
| 2026-08-06 | -1.05 | -1.03 | 284.00K | 56.36K |
| 2026-05-05 | -0.90 | -1.06 | 141.00K | 36.08K |
| 2026-02-26 | -1.08 | -0.90 | 132.00K | 18.38M |
| 2025-11-05 | -0.34 | -0.82 | 70.57M | 15.75M |
| 2025-08-06 | -1.00 | -1.00 | 75.00K | — |
| 2025-05-06 | -0.87 | -0.95 | 72.00K | 44.08K |
| 2025-02-27 | -0.81 | -1.05 | 72.00K | 50.00K |
| 2024-11-12 | -1.15 | -1.06 | 86.00K | 50.00K |
| 2024-08-08 | -1.02 | -0.89 | 72.00K | 80.00K |
| 2024-05-08 | -0.79 | -1.10 | 72.00K | 70.00K |
| 2024-02-27 | -1.35 | -1.00 | 72.00K | 154.18K |
| 2023-11-13 | -1.09 | -1.27 | 72.00K | 160.00K |
| 2023-08-08 | -1.27 | -1.29 | 72.00K | 100.00K |
| 2023-05-09 | -1.61 | -1.02 | 98.00K | 100.00K |
| 2023-03-08 | -1.13 | -0.73 | 105.00K | 510.00K |
| 2022-11-14 | -0.86 | -1.02 | 1.20M | 303.33K |
| 2022-08-15 | -1.06 | -0.90 | 256.00K | 270.33K |
| 2022-05-12 | -0.98 | -1.08 | 216.00K | 253.50K |
| 2022-03-10 | -1.32 | -0.85 | 214.00K | 342.80K |
| 2021-11-04 | -1.25 | -1.47 | 208.00K | 570.00K |
| 2021-08-11 | -2.21 | -1.52 | 1.09M | 762.88K |
| 2021-05-06 | -2.91 | -0.76 | 1.45M | 2.39M |
| 2021-03-25 | -5.31 | -1.27 | 54.00K | — |
| 2020-11-10 | -1.50 | -1.99 | — | — |
| 2020-08-05 | -1.80 | -2.47 | 168.00K | — |
| 2020-05-07 | -2.70 | -2.88 | 828.00K | — |
| 2020-03-11 | -4.65 | -3.78 | 880.00K | — |
| 2019-11-07 | -5.40 | -4.44 | 695.00K | — |
| 2019-08-07 | -4.35 | -5.59 | 2.51M | — |
| 2019-05-08 | -5.70 | -5.16 | 372.00K | — |
| 2019-03-13 | -4.95 | -4.62 | 476.00K | — |
| 2018-11-07 | -4.35 | -4.76 | 944.00K | — |
| 2018-08-07 | -4.35 | -4.35 | 2.18M | — |
| 2018-05-09 | -2.70 | -3.66 | 4.78M | — |
| 2018-03-14 | -4.35 | -4.76 | 1.19M | — |
| 2017-11-08 | -4.05 | -5.90 | 1.63M | — |
| 2017-08-11 | -5.10 | -7.05 | 718.00K | — |
| 2017-05-10 | -9.00 | -3.60 | 462.00K | — |
| 2017-03-24 | -7.23 | — | 756.00K | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Tousignant Jennifer | Sell | 10.00K | $14.41 | 144.10K |
| 2026-08-19 | Tousignant Jennifer | Buy | 10.00K | $14.41 | 144.10K |
| 2026-08-19 | Tousignant Jennifer | Sell | 10.00K | $24.50 | 245.00K |
| 2026-08-14 | Tripuraneni Radhika | Buy | 40.00K | $13.21 | 528.40K |
| 2026-08-14 | Tripuraneni Radhika | Sell | 40.00K | $13.21 | 528.40K |
| 2026-07-01 | CAIN CHRISTOPHER W. | Buy | 32.34K | $18.48 | 597.66K |
| 2026-07-01 | Ajer Jeffrey Robert | Buy | 32.34K | $18.48 | 597.66K |
| 2026-07-01 | Moses Jennifer K. | Buy | 32.34K | $18.48 | 597.66K |
| 2026-07-01 | Gheuens Sarah | Buy | 32.34K | $18.48 | 597.66K |
| 2026-07-01 | Kiselak Tomas | Buy | 32.34K | $18.48 | 597.66K |
| 2026-07-01 | Morris Arlene | Buy | 32.34K | $18.48 | 597.66K |
| 2026-05-11 | Fairmount Funds Management LLC | Buy | 1.18M | $17.00 | 20.00M |
| 2026-03-03 | Harmon Seth | Sell | 2.03K | $30.19 | 61.32K |
| 2026-03-03 | Beetham Thomas W. | Sell | 3.05K | $30.19 | 92.02K |
| 2026-03-03 | Tousignant Jennifer | Sell | 1.68K | $30.19 | 50.57K |
| 2026-03-03 | Mahoney Stephen F. | Sell | 7.41K | $30.19 | 223.65K |
| 2026-03-03 | Tousignant Jennifer | Sell | 5.17K | — | — |
| 2026-03-03 | Tousignant Jennifer | Buy | 5.17K | — | — |
| 2026-03-03 | Tousignant Jennifer | Sell | 1.72K | $29.32 | 50.55K |
| 2026-03-03 | Harmon Seth | Sell | 6.27K | — | — |
| 2026-03-03 | Harmon Seth | Buy | 6.27K | — | — |
| 2026-03-03 | Harmon Seth | Sell | 2.09K | $29.32 | 61.31K |
| 2026-03-03 | Beetham Thomas W. | Sell | 9.41K | — | — |
| 2026-03-03 | Beetham Thomas W. | Buy | 9.41K | — | — |
| 2026-03-03 | Beetham Thomas W. | Sell | 3.14K | $29.32 | 92.01K |
| 2026-03-03 | Mahoney Stephen F. | Sell | 18.36K | — | — |
| 2026-03-03 | Mahoney Stephen F. | Buy | 18.36K | — | — |
| 2026-03-03 | Mahoney Stephen F. | Sell | 7.63K | $29.32 | 223.62K |
| 2026-03-02 | Tousignant Jennifer | Buy | 119.30K | $30.25 | 3.61M |
| 2026-03-02 | Tousignant Jennifer | Buy | 23.85K | — | — |
| 2026-03-02 | Harmon Seth | Buy | 102.85K | $30.25 | 3.11M |
| 2026-03-02 | Harmon Seth | Buy | 20.55K | — | — |
| 2026-03-02 | Beetham Thomas W. | Buy | 176.55K | $30.25 | 5.34M |
| 2026-03-02 | Beetham Thomas W. | Buy | 35.30K | — | — |
| 2026-03-02 | Mahoney Stephen F. | Buy | 559.60K | $30.25 | 16.93M |
| 2026-03-02 | Mahoney Stephen F. | Buy | 111.90K | — | — |
| 2026-03-02 | Tripuraneni Radhika | Buy | 95.80K | $30.25 | 2.90M |
| 2026-03-02 | Tripuraneni Radhika | Buy | 19.15K | — | — |
| 2025-12-31 | Tousignant Jennifer | Sell | 2.27K | $31.16 | 70.80K |
| 2025-10-23 | Fairmount Funds Management LLC | Buy | 454.55K | $22.00 | 10.00M |
| 2025-07-01 | CAIN CHRISTOPHER W. | Buy | 21.00K | $14.47 | 303.87K |
| 2025-07-01 | Kiselak Tomas | Buy | 21.00K | $14.47 | 303.87K |
| 2025-07-01 | Morris Arlene | Buy | 21.00K | $14.47 | 303.87K |
| 2025-07-01 | Ajer Jeffrey Robert | Buy | 21.00K | $14.47 | 303.87K |
| 2025-07-01 | Gheuens Sarah | Buy | 21.00K | $14.47 | 303.87K |
| 2025-07-01 | Moses Jennifer K. | Buy | 21.00K | $14.47 | 303.87K |
| 2025-06-10 | Fairmount Funds Management LLC | Buy | 12.50K | $12.31 | 153.88K |
| 2025-06-10 | Fairmount Funds Management LLC | Sell | 12.50K | $12.31 | 153.88K |
| 2025-06-09 | Fairmount Funds Management LLC | Buy | 1.60K | $7.80 | 12.48K |
| 2025-06-09 | Fairmount Funds Management LLC | Sell | 1.60K | $7.80 | 12.48K |
| 2025-04-07 | Ajer Jeffrey Robert | Buy | 42.00K | $11.78 | 494.76K |
| 2025-04-07 | Ajer Jeffrey Robert | Other | 0 | — | — |
| 2025-03-10 | Tripuraneni Radhika | Buy | 310.70K | $15.58 | 4.84M |
| 2025-03-10 | Tripuraneni Radhika | Other | 40.00K | $13.21 | 528.40K |
| 2025-03-10 | CAIN CHRISTOPHER W. | Buy | 42.00K | $15.58 | 654.36K |
| 2025-03-10 | CAIN CHRISTOPHER W. | Other | 0 | — | — |
| 2025-03-03 | Harmon Seth | Other | 0 | — | — |
| 2025-03-03 | Tousignant Jennifer | Other | 0 | — | — |
| 2025-03-03 | Tousignant Jennifer | Buy | 124.07K | $14.41 | 1.79M |
| 2025-03-03 | Tousignant Jennifer | Buy | 20.68K | — | — |
| 2025-03-03 | Mahoney Stephen F. | Buy | 440.56K | $14.41 | 6.35M |
| 2025-03-03 | Mahoney Stephen F. | Buy | 73.43K | — | — |
| 2025-03-03 | Beetham Thomas W. | Buy | 225.81K | $14.41 | 3.25M |
| 2025-03-03 | Beetham Thomas W. | Buy | 37.64K | — | — |
| 2025-03-03 | Harmon Seth | Buy | 150.41K | $14.41 | 2.17M |
| 2025-03-03 | Harmon Seth | Buy | 25.07K | — | — |
| 2024-09-27 | Beetham Thomas W. | Buy | 5.00K | $23.41 | 117.05K |
| 2024-09-27 | Mahoney Stephen F. | Buy | 21.40K | $23.33 | 499.26K |
| 2024-09-13 | Fairmount Funds Management LLC | Buy | 1.60M | $18.75 | 30.00M |
| 2024-06-26 | Gheuens Sarah | Buy | 21.00K | $12.31 | 258.51K |
| 2024-06-26 | Morris Arlene | Buy | 21.00K | $12.31 | 258.51K |
| 2024-06-26 | Moses Jennifer K. | Buy | 21.00K | $12.31 | 258.51K |
| 2024-06-26 | Harwin Peter Evan | Buy | 21.00K | $12.31 | 258.51K |
| 2024-06-26 | Kiselak Tomas | Buy | 21.00K | $12.31 | 258.51K |
| 2024-03-28 | Fairmount Funds Management LLC | Buy | 5.86K | — | — |
| 2024-03-28 | Fairmount Funds Management LLC | Buy | 22.00K | — | — |
| 2024-03-28 | Fairmount Funds Management LLC | Sell | 5.86K | — | — |
| 2024-03-28 | Fairmount Funds Management LLC | Sell | 22.00K | — | — |
| 2024-02-12 | Tousignant Jennifer | Other | 0 | — | — |
| 2024-02-12 | Tousignant Jennifer | Buy | 290.00K | $19.68 | 5.71M |
| 2024-02-05 | Ciulla Thomas | Buy | 50.00K | $18.70 | 935.00K |
| 2024-01-22 | Fairmount Funds Management LLC | Buy | 476.19K | $21.00 | 10.00M |
| 2024-01-03 | Ciulla Thomas | Sell | 0 | — | — |
| 2024-01-03 | Ciulla Thomas | Sell | 250.00K | $33.06 | 8.27M |
| 2024-01-03 | Ciulla Thomas | Sell | 270.00K | $13.76 | 3.72M |
| 2024-01-03 | Ciulla Thomas | Sell | 50.00K | $28.22 | 1.41M |
| 2023-11-10 | Harmon Seth | Buy | 270.00K | $13.76 | 3.72M |
| 2023-10-30 | Fairmount Funds Management LLC | Buy | 48.46K | — | — |
| 2023-10-30 | Beetham Thomas W. | Other | 0 | — | — |
| 2023-10-30 | Beetham Thomas W. | Buy | 474.40K | $13.02 | 6.18M |
| 2023-10-30 | Mahoney Stephen F. | Buy | 1.26M | $13.02 | 16.40M |
| 2023-10-30 | Mahoney Stephen F. | Other | 0 | — | — |
| 2023-09-21 | Gheuens Sarah | Buy | 40.00K | $15.74 | 629.60K |
| 2023-09-21 | Gheuens Sarah | Other | 0 | — | — |
| 2023-09-12 | Harmon Seth | Sell | 175.00K | $24.50 | 4.29M |
| 2023-06-16 | Meisner Lara | Sell | 28 | $23.03 | 645 |
| 2023-06-16 | Meisner Lara | Buy | 27 | $23.03 | 622 |
| 2023-06-16 | Meisner Lara | Sell | 27 | $28.35 | 765 |
| 2023-06-15 | Meisner Lara | Sell | 2.27K | $23.03 | 52.26K |
| 2023-06-15 | Meisner Lara | Buy | 2.27K | $23.03 | 52.26K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 227, holders -3 vs prior quarter. Ownership 126.86%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 16.60M | 1.23M | +7.97% | 305.03M |
| BLACKROCK, INC. | 8.55M | 720.01K | +9.19% | 157.09M |
| BELLEVUE GROUP AG | 6.73M | 5.76K | +0.09% | 123.67M |
| PARADIGM BIOCAPITAL ADVISORS LP | 6.72M | 3.57M | +113.53% | 123.52M |
| KYNAM CAPITAL MANAGEMENT, LP | 6.45M | 4.11M | +175.61% | 118.56M |
| STATE STREET CORP | 6.12M | 1.45M | +31.07% | 112.52M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.75M | 2.54M | +79.30% | 105.60M |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 5.09M | 1.18M | +30.05% | 93.52M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.58M | 409.66K | +9.83% | 84.08M |
| DEEP TRACK CAPITAL, LP | 3.59M | 2.20M | +157.74% | 66.00M |
| VENROCK ADVISER, LLC | 3.26M | -624.79K | -16.09% | 59.85M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.13M | 49.81K | +1.62% | 57.47M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.75M | 1.11M | +67.70% | 50.57M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.50M | 168.66K | +7.23% | 45.97M |
| AVORO CAPITAL ADVISORS LLC | 2.50M | 1.00M | +66.67% | 45.92M |
| BAKER BROS. ADVISORS LP | 2.38M | 411.35K | +20.86% | 43.78M |
| POINT72 ASSET MANAGEMENT, L.P. | 2.34M | 2.02M | +625.82% | 43.04M |
| CALIGAN PARTNERS LP | 2.19M | 2.19M | New | 40.30M |
| NOVO HOLDINGS A/S | 2.13M | 135.00K | +6.75% | 39.22M |
| TANG CAPITAL MANAGEMENT LLC | 1.79M | 0 | 0.00% | 32.93M |
| FISHER ASSET MANAGEMENT, LLC | 1.75M | -17.45K | -0.99% | 32.16M |
| CANDRIAM S.C.A. | 1.71M | 995.96K | +139.93% | 31.34M |
| GOLDMAN SACHS GROUP INC | 1.69M | 99.36K | +6.24% | 31.07M |
| FIRST TURN MANAGEMENT, LLC | 1.67M | 758.66K | +83.25% | 30.68M |
| DIMENSIONAL FUND ADVISORS LP | 1.61M | 1.08M | +204.20% | 29.61M |
Insights · Dividends · Forecast · Financials · Learn